words lines 0 60 0 20 top 50% bottom top 1 0 0 .22 back 1 0 .001 1 .1 1.5 none top bottom center center true 1 none top top center top true 0 200 .001 none
top bottom top center true 1 none top bottom bottom bottom true 1 none

CEO Raman Singh speaks about his mission to bring accessibility to the core of pharmaceutical innovation while being committed to ESG.

Oct 12, 2022

Juniper Biologics

Author


Mind Your Business: Striking a balance between pharmaceutical innovation and accessibility to medication

The pharmaceutical industry has gone through heaps and bounds of multiple shake ups due to the Covid-19 pandemic. And as we move forward, it has become more important than ever to strike a balance between pharmaceutical innovation and accessibility to medication.

Raman Singh, Chief Executive Officer, Juniper Biologics shares with us on how his company are looking ways to support Singapore’s efforts to be the next frontier in pharmaceutical services. 

CARIS MEA
Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa
Pharmaceutical Company of the Year
Juniper Biologics Named “Pharmaceutical Company of the Year” at Corporate LiveWire Global Awards USA – English 
APAC Insider
Advancing Healthcare Innovation: Juniper Biologics Recognized as the Best Novel Therapy R&D and Commercialization Company 2024 by APAC Insider
Follow us on Facebook